Back to Search
LISA EHRLICH, M.D.
M.D.
Internal Medicine Physician
NPI: 1356442768IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
K4048(TX)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Class of 1993
Research & Publications (20)
Reductive isolation from bone marrow and blood implicates common lymphoid progenitors as the major source of thymopoiesis.
PMID 18927436·Blood·2009
7-preclinical
Developing a methodology for three-dimensional correlation of PET-CT images and whole-mount histopathology in non-small-cell lung cancer.
PMID 19008992·Curr Oncol·2008
8-other
Low ligand requirement for deletion and lack of synapses in positive selection enforce the gauntlet of thymic T cell maturation.
PMID 18993085·Immunity·2008
7-preclinical
18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
PMID 19128681·J Otolaryngol Head Neck Surg·2008
8-other
Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature.
PMID 18980461·J Palliat Med·2008
5-case
Space-time considerations for hematopoietic stem cell transplantation.
PMID 18651698·Eur J Immunol·2008
6-review
Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting.
PMID 18555885·Virology·2008
7-preclinical
PET/CT fusion technology: its role in managing recurrent, well-differentiated thyroid cancer.
PMID 18248717·Can J Surg·2008
5-case
Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomography.
PMID 18164420·Ann Diagn Pathol·2008
8-other
Pathophysiology of multiple myeloma bone disease.
PMID 17996587·Hematol Oncol Clin North Am·2007
6-review
Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma.
PMID 17121904·Clin Cancer Res·2006
8-other
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression.
PMID 16831924·Ann N Y Acad Sci·2006
7-preclinical
Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
PMID 15699119·J Immunol·2005
7-preclinical
The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma.
PMID 16313353·Immunol Rev·2005
6-review
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma.
PMID 15878977·Blood·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2535 KIRBY DR
HOUSTON, TX 77019 - Phone
- (713) 800-8800
Quick Facts
- NPI
- 1356442768
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile